283 related articles for article (PubMed ID: 33019399)
1. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.
Cui K; Ou Y; Shen Y; Li S; Sun Z
Medicine (Baltimore); 2020 Oct; 99(40):e22242. PubMed ID: 33019399
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
[TBL] [Abstract][Full Text] [Related]
3. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
[TBL] [Abstract][Full Text] [Related]
4. Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma.
Guo W; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang M; Wang G; Chen WQ; Guo L; Lu RQ; Zhou CH; Zhang X; Shi YH; Qiu SJ; Pan BS; Cao Y; Zhou J; Yang XR; Fan J
Clin Cancer Res; 2018 May; 24(9):2203-2213. PubMed ID: 29374055
[No Abstract] [Full Text] [Related]
5. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.
Cheng Y; Luo L; Zhang J; Zhou M; Tang Y; He G; Lu Y; Wang Z; Pan M
J Gastrointest Surg; 2019 Dec; 23(12):2354-2361. PubMed ID: 30805878
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
7. Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma.
Ma XL; Jiang M; Zhao Y; Wang BL; Shen MN; Zhou Y; Zhang CY; Sun YF; Chen JW; Hu B; Gong ZJ; Zhang X; Cao Y; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Ann Surg Oncol; 2018 Jun; 25(6):1686-1694. PubMed ID: 29626309
[TBL] [Abstract][Full Text] [Related]
8. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.
Zhao L; Zheng Z; Liu Y; Liu F; Li X; Wu Z
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6035-6048. PubMed ID: 36633681
[TBL] [Abstract][Full Text] [Related]
9. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
[TBL] [Abstract][Full Text] [Related]
10. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
[TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ
Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159
[TBL] [Abstract][Full Text] [Related]
12. Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis.
Fan JL; Yang YF; Yuan CH; Chen H; Wang FB
Cell Physiol Biochem; 2015; 37(2):629-40. PubMed ID: 26344495
[TBL] [Abstract][Full Text] [Related]
13. High Epithelial Cell Adhesion Molecule-Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization.
Shen J; Wang WS; Zhu XL; Ni CF
J Vasc Interv Radiol; 2018 Dec; 29(12):1678-1684. PubMed ID: 30392801
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
Guo W; Yang XR; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang X; Zhou J; Fan J
Clin Cancer Res; 2014 Sep; 20(18):4794-805. PubMed ID: 25009297
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients.
Zhao L; Song J; Sun Y; Ju Q; Mu H; Dong X; Ding J; Liu Y; Wang X; Sun L; Wu J; Jiao Y; Lu S; Zhao X
Cancer Med; 2023 Jul; 12(13):13912-13927. PubMed ID: 37337648
[TBL] [Abstract][Full Text] [Related]
16. Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma.
Hao Q; Han Y; Xia W; Wang Q; Qian H
Can J Gastroenterol Hepatol; 2019; 2019():1684039. PubMed ID: 31187026
[TBL] [Abstract][Full Text] [Related]
17. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood.
Wang Z; Luo L; Cheng Y; He G; Peng B; Gao Y; Jiang ZS; Pan M
J Gastrointest Surg; 2018 Apr; 22(4):633-639. PubMed ID: 29159757
[TBL] [Abstract][Full Text] [Related]
19. Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
Ni HH; Yang XH; Yang CL; Zhang Q; Xu JX; Qi LN; Xiang BD
Biomed Res Int; 2022; 2022():7305953. PubMed ID: 35880030
[TBL] [Abstract][Full Text] [Related]
20. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]